Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-590-3p AADAT 0.86 0.00013 -0.43 0.07498 miRanda -0.19 0.00309 NA
2 hsa-miR-590-3p AAK1 0.86 0.00013 -0.1 0.28347 PITA -0.16 0 NA
3 hsa-miR-590-3p AASS 0.86 0.00013 -0.79 0.00013 miRanda -0.5 0 NA
4 hsa-miR-590-3p ABAT 0.86 0.00013 -1.27 0 PITA; miRanda -0.18 0.01008 NA
5 hsa-miR-590-3p ABCA1 0.86 0.00013 0.61 0.0002 miRanda -0.24 0 NA
6 hsa-miR-361-5p ABCA10 0.54 0 -0.57 0.03674 miRanda -0.48 0.00391 NA
7 hsa-miR-590-3p ABCA10 0.86 0.00013 -0.57 0.03674 miRanda -0.6 0 NA
8 hsa-miR-590-3p ABCA4 0.86 0.00013 -1.16 1.0E-5 miRanda -0.2 0.00484 NA
9 hsa-miR-590-3p ABCA5 0.86 0.00013 -0.62 0.00028 miRanda -0.13 0.00548 NA
10 hsa-miR-590-3p ABCA6 0.86 0.00013 -1.09 0.0003 miRanda -0.67 0 NA
11 hsa-miR-361-5p ABCA8 0.54 0 -2.99 0 miRanda -1.5 0 NA
12 hsa-miR-590-3p ABCA8 0.86 0.00013 -2.99 0 miRanda -0.96 0 NA
13 hsa-miR-590-3p ABCA9 0.86 0.00013 -1.38 0.00017 miRanda -0.91 0 NA
14 hsa-miR-590-3p ABCB1 0.86 0.00013 -0.7 0.00397 miRanda -0.25 0.00011 NA
15 hsa-miR-590-3p ABCB4 0.86 0.00013 0.15 0.50554 miRanda -0.21 0.00059 NA
16 hsa-miR-361-5p ABCB5 0.54 0 -0.96 0.04077 miRanda -0.68 0.01555 NA
17 hsa-miR-590-3p ABCB5 0.86 0.00013 -0.96 0.04077 miRanda -0.94 0 NA
18 hsa-miR-590-3p ABCC9 0.86 0.00013 -0.47 0.14121 miRanda -0.92 0 NA
19 hsa-miR-361-5p ABCD2 0.54 0 -1.04 0.0005 miRanda -1.07 0 NA
20 hsa-miR-590-3p ABCD2 0.86 0.00013 -1.04 0.0005 miRanda -0.29 0.00029 NA
21 hsa-miR-590-3p ABCG2 0.86 0.00013 -1.55 0 miRanda -0.34 0.00011 NA
22 hsa-miR-590-3p ABHD12B 0.86 0.00013 0.27 0.58173 miRanda -0.42 0.0012 NA
23 hsa-miR-125a-5p ABHD2 -0.26 0.11611 0.47 0.00888 miRanda -0.19 0.00441 NA
24 hsa-miR-590-3p ABI2 0.86 0.00013 0.18 0.14787 miRanda -0.24 0 NA
25 hsa-miR-590-3p ABI3BP 0.86 0.00013 -2.06 0 miRanda -0.93 0 NA
26 hsa-miR-361-5p ABL1 0.54 0 -0.21 0.07804 miRanda -0.2 0.0072 NA
27 hsa-miR-590-3p ABL2 0.86 0.00013 0.82 0 PITA -0.12 0.00011 NA
28 hsa-miR-361-5p ACACB 0.54 0 -1.41 0 miRanda -0.48 0.00065 NA
29 hsa-miR-361-5p ACAD8 0.54 0 -0.33 0.0001 miRanda -0.12 0.02142 NA
30 hsa-miR-590-3p ACADL 0.86 0.00013 -3.43 0 miRanda -0.6 0 NA
31 hsa-miR-590-3p ACADM 0.86 0.00013 -1.05 0 miRanda -0.13 0.00096 NA
32 hsa-miR-361-5p ACADSB 0.54 0 -0.98 0 miRanda -0.25 0.00853 NA
33 hsa-miR-590-3p ACADSB 0.86 0.00013 -0.98 0 miRanda -0.14 0.00102 NA
34 hsa-miR-590-3p ACOT2 0.86 0.00013 -0.72 0 miRanda -0.11 0.00115 NA
35 hsa-miR-590-3p ACOX2 0.86 0.00013 -1.86 0 miRanda -0.57 0 NA
36 hsa-miR-125a-5p ACPP -0.26 0.11611 -0.16 0.64505 miRanda -0.43 0.00059 NA
37 hsa-miR-590-3p ACSL1 0.86 0.00013 -0.58 4.0E-5 miRanda -0.19 0 NA
38 hsa-miR-361-5p ACSL6 0.54 0 -1.59 0 miRanda -0.53 0.00792 NA
39 hsa-miR-590-3p ACSL6 0.86 0.00013 -1.59 0 miRanda -0.29 0.0014 NA
40 hsa-miR-590-3p ACSM5 0.86 0.00013 -1.28 5.0E-5 miRanda -0.39 1.0E-5 NA
41 hsa-miR-590-3p ACSS3 0.86 0.00013 -0.4 0.15502 miRanda -0.41 0 NA
42 hsa-miR-590-3p ACTB 0.86 0.00013 -0.25 0.01736 miRanda -0.14 0 NA
43 hsa-miR-361-5p ACTC1 0.54 0 -1.57 0.00051 miRanda -1.26 0 NA
44 hsa-miR-590-3p ACTC1 0.86 0.00013 -1.57 0.00051 miRanda -0.88 0 NA
45 hsa-miR-361-5p ACTG1 0.54 0 0 0.98112 miRNAWalker2 validate; PITA; miRanda -0.14 0.03668 NA
46 hsa-miR-590-3p ACTG2 0.86 0.00013 -2.75 0 miRanda -1.51 0 NA
47 hsa-miR-590-3p ACTN1 0.86 0.00013 0.14 0.44606 miRanda -0.48 0 NA
48 hsa-miR-15a-5p ACTR1A 1.08 0 -0.4 0 miRNAWalker2 validate -0.15 0 NA
49 hsa-miR-590-3p ACVR1 0.86 0.00013 0.28 0.00234 miRanda -0.11 1.0E-5 NA
50 hsa-miR-590-3p ACVR2A 0.86 0.00013 -0.41 0.00039 PITA; miRanda -0.18 0 NA
51 hsa-miR-590-3p ADAL 0.86 0.00013 -0.34 0.01893 miRanda -0.12 0.00194 NA
52 hsa-miR-125a-5p ADAM10 -0.26 0.11611 0.68 0 miRanda -0.23 0 NA
53 hsa-miR-361-5p ADAM19 0.54 0 0.19 0.3039 miRanda -0.29 0.00766 NA
54 hsa-miR-590-3p ADAM19 0.86 0.00013 0.19 0.3039 miRanda -0.19 7.0E-5 NA
55 hsa-miR-590-3p ADAM22 0.86 0.00013 0.64 0.00696 PITA; miRanda -0.31 0 NA
56 hsa-miR-590-3p ADAM23 0.86 0.00013 -0.71 0.00863 miRanda -0.53 0 NA
57 hsa-miR-590-3p ADAM32 0.86 0.00013 0.73 0.00299 miRanda -0.39 0 NA
58 hsa-miR-590-3p ADAM33 0.86 0.00013 -1.82 1.0E-5 miRanda -1.1 0 NA
59 hsa-miR-590-3p ADAMTS1 0.86 0.00013 -1.46 0 miRanda -0.57 0 NA
60 hsa-miR-590-3p ADAMTS16 0.86 0.00013 0.41 0.25777 miRanda -0.4 5.0E-5 NA
61 hsa-miR-590-3p ADAMTS17 0.86 0.00013 -0.45 0.11385 miRanda -0.26 0.00067 NA
62 hsa-miR-590-3p ADAMTS19 0.86 0.00013 -1.3 0.01069 PITA; miRanda -0.62 1.0E-5 NA
63 hsa-miR-590-3p ADAMTS3 0.86 0.00013 0.38 0.04723 miRanda -0.31 0 NA
64 hsa-miR-590-3p ADAMTS5 0.86 0.00013 0.19 0.27716 PITA; miRanda -0.29 0 NA
65 hsa-miR-590-3p ADAMTS6 0.86 0.00013 1.2 0 miRanda -0.24 4.0E-5 NA
66 hsa-miR-590-3p ADAMTS8 0.86 0.00013 -1.48 0.00069 miRanda -0.98 0 NA
67 hsa-miR-590-3p ADAMTS9 0.86 0.00013 0.8 3.0E-5 miRanda -0.22 3.0E-5 NA
68 hsa-miR-590-3p ADAMTSL1 0.86 0.00013 -1.98 0 miRanda -0.48 0 NA
69 hsa-miR-590-3p ADAMTSL3 0.86 0.00013 -1.56 0 miRanda -0.81 0 NA
70 hsa-miR-590-3p ADARB1 0.86 0.00013 -0.34 0.06631 miRanda -0.44 0 NA
71 hsa-miR-590-3p ADARB2 0.86 0.00013 -2.03 0 miRanda -0.51 0 NA
72 hsa-miR-361-5p ADCY2 0.54 0 -1.53 4.0E-5 PITA; miRanda -1.04 0 NA
73 hsa-miR-361-5p ADCY9 0.54 0 -0.36 0.01911 miRanda -0.32 0.00051 NA
74 hsa-miR-590-3p ADCY9 0.86 0.00013 -0.36 0.01911 miRanda -0.34 0 NA
75 hsa-miR-361-5p ADCYAP1 0.54 0 -1.7 0.00038 miRanda -1.41 0 NA
76 hsa-miR-590-3p ADCYAP1 0.86 0.00013 -1.7 0.00038 PITA; miRanda -0.85 0 NA
77 hsa-miR-590-3p ADD1 0.86 0.00013 -0.51 0 PITA; miRanda -0.19 0 NA
78 hsa-miR-590-3p ADH1A 0.86 0.00013 -2.38 0 miRanda -0.67 0 NA
79 hsa-miR-590-3p ADH1B 0.86 0.00013 -3.72 0 miRanda -1.09 0 NA
80 hsa-miR-590-3p ADH4 0.86 0.00013 -2.17 0.00155 miRanda -0.45 0.01695 NA
81 hsa-miR-590-3p ADH5 0.86 0.00013 -0.37 0.00013 miRanda -0.16 0 NA
82 hsa-miR-361-5p ADHFE1 0.54 0 -2.92 0 miRanda -1.34 0 NA
83 hsa-miR-590-3p ADIPOQ 0.86 0.00013 -4.48 0 PITA; miRanda -1.08 0 NA
84 hsa-miR-361-5p ADRA2A 0.54 0 0.02 0.95612 miRanda -0.61 0.01464 NA
85 hsa-miR-590-3p ADRB2 0.86 0.00013 -2.78 0 PITA; miRanda -0.49 0 NA
86 hsa-miR-125a-5p AEN -0.26 0.11611 0.71 0 miRanda -0.15 0.00216 NA
87 hsa-miR-590-3p AFAP1 0.86 0.00013 0.34 0.01222 PITA; miRanda -0.3 0 NA
88 hsa-miR-590-3p AFAP1L2 0.86 0.00013 -0.28 0.15434 miRanda -0.3 0 NA
89 hsa-miR-590-3p AFF1 0.86 0.00013 -0.38 0.00053 PITA; miRanda -0.2 0 NA
90 hsa-miR-590-3p AFF3 0.86 0.00013 -2.37 0 PITA; miRanda -0.79 0 NA
91 hsa-miR-361-5p AFF4 0.54 0 -0.27 0.01565 miRanda -0.18 0.00599 NA
92 hsa-miR-590-3p AFF4 0.86 0.00013 -0.27 0.01565 PITA; miRanda -0.21 0 NA
93 hsa-miR-590-3p AGAP1 0.86 0.00013 -0.05 0.72151 miRanda -0.16 0 NA
94 hsa-miR-361-5p AGBL5 0.54 0 -0.73 0 miRanda -0.18 0.02806 NA
95 hsa-miR-125a-5p AGGF1 -0.26 0.11611 0.11 0.14733 miRanda -0.15 0 NA
96 hsa-miR-590-3p AGL 0.86 0.00013 -0.17 0.16618 PITA; miRanda -0.16 0 NA
97 hsa-miR-590-3p AGTR1 0.86 0.00013 -2.47 0 miRanda -1.34 0 NA
98 hsa-miR-361-5p AGTR2 0.54 0 -1.87 0.00044 PITA; miRanda -0.96 0.00317 NA
99 hsa-miR-590-3p AGTR2 0.86 0.00013 -1.87 0.00044 PITA; miRanda -1.09 0 NA
100 hsa-miR-590-3p AHCYL1 0.86 0.00013 -0.48 0 miRanda -0.1 0 NA
101 hsa-miR-361-5p AHCYL2 0.54 0 -0.32 0.14924 miRanda -0.5 0.00021 NA
102 hsa-miR-125a-5p AHI1 -0.26 0.11611 0.25 0.03721 miRanda -0.13 0.00423 NA
103 hsa-miR-590-3p AHI1 0.86 0.00013 0.25 0.03721 miRanda -0.16 0 NA
104 hsa-miR-361-5p AHNAK 0.54 0 -1.21 0 miRanda -0.71 0 NA
105 hsa-miR-590-3p AHNAK 0.86 0.00013 -1.21 0 miRanda -0.49 0 NA
106 hsa-miR-590-3p AHSA2 0.86 0.00013 0.53 0.00119 miRanda -0.11 0.01532 NA
107 hsa-miR-125a-5p AIFM1 -0.26 0.11611 -0.04 0.71464 miRanda -0.12 0.00457 NA
108 hsa-miR-590-3p AK3 0.86 0.00013 -0.7 0 miRanda -0.1 0.00087 NA
109 hsa-miR-361-5p AK5 0.54 0 -1.47 0 miRanda -0.62 0.00075 NA
110 hsa-miR-590-3p AK5 0.86 0.00013 -1.47 0 miRanda -0.63 0 NA
111 hsa-miR-125a-5p AKAP11 -0.26 0.11611 0.2 0.09825 miRanda -0.15 0.0008 NA
112 hsa-miR-590-3p AKAP11 0.86 0.00013 0.2 0.09825 miRanda -0.21 0 NA
113 hsa-miR-361-5p AKAP12 0.54 0 -0.93 0.0028 miRanda -0.68 0.00031 NA
114 hsa-miR-590-3p AKAP12 0.86 0.00013 -0.93 0.0028 miRanda -0.82 0 NA
115 hsa-miR-361-5p AKAP6 0.54 0 -1.59 3.0E-5 miRanda -0.88 0.00012 NA
116 hsa-miR-590-3p AKAP6 0.86 0.00013 -1.59 3.0E-5 PITA; miRanda -1.15 0 NA
117 hsa-miR-590-3p AKAP7 0.86 0.00013 -0.63 0.00332 miRanda -0.15 0.01252 NA
118 hsa-miR-361-5p AKNAD1 0.54 0 -0.46 0.00016 miRanda -0.27 0.00021 NA
119 hsa-miR-590-3p AKNAD1 0.86 0.00013 -0.46 0.00016 miRanda -0.2 0 NA
120 hsa-miR-361-5p AKR1B10 0.54 0 -3.97 0 miRanda -2 1.0E-5 NA
121 hsa-miR-590-3p AKR1E2 0.86 0.00013 0.15 0.6468 miRanda -0.21 0.01521 NA
122 hsa-miR-361-5p AKR7A2 0.54 0 -0.7 0 miRanda -0.26 0.00055 NA
123 hsa-miR-15a-5p AKT3 1.08 0 -0.27 0.18865 miRNAWalker2 validate; miRTarBase -0.6 0 NA
124 hsa-miR-590-3p AKTIP 0.86 0.00013 -0.38 0.00082 miRanda -0.21 0 NA
125 hsa-miR-590-3p ALAD 0.86 0.00013 -0.72 0 miRanda -0.11 3.0E-5 NA
126 hsa-miR-590-3p ALDH1A3 0.86 0.00013 0.12 0.61313 miRanda -0.4 0 NA
127 hsa-miR-590-3p ALDH1L1 0.86 0.00013 -2.34 0 miRanda -0.66 0 NA
128 hsa-miR-590-3p ALDH1L2 0.86 0.00013 0.23 0.32096 miRanda -0.28 1.0E-5 NA
129 hsa-miR-361-5p ALDH6A1 0.54 0 -1.2 0 miRanda -0.34 9.0E-5 NA
130 hsa-miR-590-3p ALDH6A1 0.86 0.00013 -1.2 0 miRanda -0.18 0 NA
131 hsa-miR-125a-5p ALPK1 -0.26 0.11611 0.31 0.03014 miRanda -0.14 0.00622 NA
132 hsa-miR-590-3p ALPK3 0.86 0.00013 -0.07 0.79023 miRanda -0.58 0 NA
133 hsa-miR-590-3p ALS2CR11 0.86 0.00013 0.94 0.00621 miRanda -0.4 1.0E-5 NA
134 hsa-miR-361-5p AMFR 0.54 0 -0.4 1.0E-5 miRanda -0.19 0.00074 NA
135 hsa-miR-590-3p AMIGO1 0.86 0.00013 -0.83 0.00159 miRanda -0.48 0 NA
136 hsa-miR-590-3p AMN1 0.86 0.00013 -0.3 0.02124 miRanda -0.11 0.00183 NA
137 hsa-miR-590-3p AMOTL2 0.86 0.00013 0.15 0.30776 miRanda -0.13 0.00055 NA
138 hsa-miR-590-3p AMT 0.86 0.00013 -1.49 0 miRanda -0.19 0.00371 NA
139 hsa-miR-590-3p AMY2B 0.86 0.00013 0.17 0.24319 miRanda -0.17 4.0E-5 NA
140 hsa-miR-15a-5p ANAPC16 1.08 0 -0.56 0 miRNAWalker2 validate -0.14 0.00018 NA
141 hsa-miR-590-3p ANAPC16 0.86 0.00013 -0.56 0 miRanda -0.14 0 NA
142 hsa-miR-590-3p ANGPT1 0.86 0.00013 -1.12 0 PITA; miRanda -0.54 0 NA
143 hsa-miR-125a-5p ANGPT2 -0.26 0.11611 1.53 0 miRanda -0.17 0.02642 NA
144 hsa-miR-590-3p ANGPTL1 0.86 0.00013 -2.71 0 PITA; miRanda -1.33 0 NA
145 hsa-miR-361-5p ANGPTL2 0.54 0 -0.02 0.91748 miRanda -0.49 0.00032 NA
146 hsa-miR-590-3p ANK2 0.86 0.00013 -1.6 1.0E-5 PITA; miRanda -0.96 0 NA
147 hsa-miR-590-3p ANK3 0.86 0.00013 -0.55 0.00086 PITA; miRanda -0.2 1.0E-5 NA
148 hsa-miR-590-3p ANKAR 0.86 0.00013 -0.16 0.29664 miRanda -0.26 0 NA
149 hsa-miR-590-3p ANKDD1A 0.86 0.00013 -0.34 0.0368 PITA; miRanda -0.37 0 NA
150 hsa-miR-361-5p ANKFY1 0.54 0 -0.04 0.63304 miRanda -0.11 0.04447 NA
NumGOOverlapSizeP ValueAdj. P Value
1 NEUROGENESIS 379 1402 1.942e-35 9.038e-32
2 CELL DEVELOPMENT 361 1426 1.222e-27 2.844e-24
3 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 407 1672 1.908e-27 2.96e-24
4 CELLULAR COMPONENT MORPHOGENESIS 253 900 2.881e-26 3.352e-23
5 CARDIOVASCULAR SYSTEM DEVELOPMENT 227 788 3.588e-25 2.782e-22
6 CIRCULATORY SYSTEM DEVELOPMENT 227 788 3.588e-25 2.782e-22
7 CELL PROJECTION ORGANIZATION 245 902 3.533e-23 2.055e-20
8 CENTRAL NERVOUS SYSTEM DEVELOPMENT 239 872 3.378e-23 2.055e-20
9 NEURON DIFFERENTIATION 238 874 1.08e-22 5.583e-20
10 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 211 750 4.703e-22 2.188e-19
11 HEAD DEVELOPMENT 202 709 7.454e-22 3.153e-19
12 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 160 513 9.457e-22 3.667e-19
13 REGULATION OF CELL DIFFERENTIATION 353 1492 1.775e-21 6.355e-19
14 CELL PART MORPHOGENESIS 185 633 2.015e-21 6.697e-19
15 NEURON PROJECTION DEVELOPMENT 163 545 4.362e-20 1.353e-17
16 RESPONSE TO ENDOGENOUS STIMULUS 339 1450 9.46e-20 2.751e-17
17 NEURON DEVELOPMENT 191 687 1.971e-19 5.396e-17
18 NEURON PROJECTION MORPHOGENESIS 130 402 2.327e-19 5.761e-17
19 TISSUE DEVELOPMENT 350 1518 2.352e-19 5.761e-17
20 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 280 1142 2.48e-19 5.769e-17
21 VASCULATURE DEVELOPMENT 144 469 5.304e-19 1.175e-16
22 REGULATION OF CELL DEVELOPMENT 219 836 9.379e-19 1.984e-16
23 REGULATION OF NEURON DIFFERENTIATION 161 554 1.61e-18 3.258e-16
24 BIOLOGICAL ADHESION 256 1032 2.037e-18 3.948e-16
25 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 248 1008 2.154e-17 4.008e-15
26 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 118 368 2.254e-17 4.033e-15
27 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 238 957 2.571e-17 4.43e-15
28 REGULATION OF NEURON PROJECTION DEVELOPMENT 126 408 5.301e-17 8.81e-15
29 BLOOD VESSEL MORPHOGENESIS 116 364 7.071e-17 1.135e-14
30 HEART DEVELOPMENT 137 466 2.178e-16 3.311e-14
31 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 247 1021 2.206e-16 3.311e-14
32 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 130 437 4.654e-16 6.767e-14
33 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 314 1395 7.454e-16 1.051e-13
34 REGULATION OF TRANSPORT 386 1804 1.135e-15 1.554e-13
35 REGULATION OF CELL PROJECTION ORGANIZATION 153 558 3.209e-15 4.267e-13
36 SYNAPSE ORGANIZATION 60 145 5.88e-15 7.6e-13
37 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 288 1275 8.55e-15 1.075e-12
38 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 378 1784 1.103e-14 1.35e-12
39 POSITIVE REGULATION OF MOLECULAR FUNCTION 379 1791 1.231e-14 1.469e-12
40 REGULATION OF MEMBRANE POTENTIAL 105 343 4.114e-14 4.669e-12
41 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 80 232 4.073e-14 4.669e-12
42 POSITIVE REGULATION OF CELL DEVELOPMENT 132 472 5.331e-14 5.906e-12
43 SINGLE ORGANISM BEHAVIOR 113 384 8.903e-14 9.634e-12
44 POSITIVE REGULATION OF NEURON DIFFERENTIATION 96 306 9.809e-14 1.037e-11
45 RESPONSE TO NITROGEN COMPOUND 207 859 1.054e-13 1.089e-11
46 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 261 1152 1.225e-13 1.213e-11
47 BEHAVIOR 140 516 1.204e-13 1.213e-11
48 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 174 689 1.46e-13 1.415e-11
49 TISSUE MORPHOGENESIS 143 533 1.697e-13 1.611e-11
50 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 350 1656 1.797e-13 1.673e-11
51 REGULATION OF CELLULAR COMPONENT MOVEMENT 189 771 2.488e-13 2.27e-11
52 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 94 303 3.717e-13 3.326e-11
53 POSITIVE REGULATION OF CELL DIFFERENTIATION 198 823 4.394e-13 3.857e-11
54 RESPONSE TO HORMONE 210 893 8.911e-13 7.678e-11
55 REGULATION OF PHOSPHORUS METABOLIC PROCESS 340 1618 9.259e-13 7.833e-11
56 ANGIOGENESIS 90 293 2.188e-12 1.818e-10
57 POSITIVE REGULATION OF CELL COMMUNICATION 323 1532 2.427e-12 1.981e-10
58 CELLULAR RESPONSE TO HORMONE STIMULUS 143 552 3.048e-12 2.446e-10
59 POSITIVE REGULATION OF CATALYTIC ACTIVITY 319 1518 5.135e-12 3.982e-10
60 CELLULAR RESPONSE TO NITROGEN COMPOUND 133 505 5.092e-12 3.982e-10
61 EMBRYO DEVELOPMENT 207 894 6.142e-12 4.685e-10
62 ORGAN MORPHOGENESIS 197 841 6.834e-12 5.085e-10
63 REGULATION OF SYSTEM PROCESS 133 507 6.885e-12 5.085e-10
64 LOCOMOTION 246 1114 1.116e-11 8.112e-10
65 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 188 799 1.405e-11 1.006e-09
66 RESPONSE TO OXYGEN CONTAINING COMPOUND 292 1381 2.228e-11 1.571e-09
67 FOREBRAIN DEVELOPMENT 101 357 2.398e-11 1.666e-09
68 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 288 1360 2.599e-11 1.778e-09
69 RESPONSE TO WOUNDING 142 563 2.962e-11 1.998e-09
70 NEGATIVE REGULATION OF CELL COMMUNICATION 258 1192 3.081e-11 2.048e-09
71 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 187 801 3.243e-11 2.125e-09
72 REGULATION OF PROTEIN MODIFICATION PROCESS 347 1710 5.448e-11 3.473e-09
73 REGULATION OF CELL MORPHOGENESIS 139 552 5.429e-11 3.473e-09
74 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 95 337 1.159e-10 7.287e-09
75 REGULATION OF HYDROLASE ACTIVITY 279 1327 1.222e-10 7.582e-09
76 POSITIVE REGULATION OF GENE EXPRESSION 349 1733 1.25e-10 7.656e-09
77 INTRACELLULAR SIGNAL TRANSDUCTION 321 1572 1.513e-10 9.142e-09
78 REGULATION OF ION TRANSPORT 145 592 1.736e-10 1.036e-08
79 SYNAPSE ASSEMBLY 32 69 3.694e-10 2.175e-08
80 REGULATION OF GTPASE ACTIVITY 159 673 4.039e-10 2.349e-08
81 EYE DEVELOPMENT 91 326 4.964e-10 2.851e-08
82 REGULATION OF CELLULAR COMPONENT BIOGENESIS 176 767 5.285e-10 2.999e-08
83 CIRCULATORY SYSTEM PROCESS 99 366 5.742e-10 3.219e-08
84 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 215 983 5.886e-10 3.26e-08
85 TELENCEPHALON DEVELOPMENT 70 228 6.115e-10 3.347e-08
86 RESPONSE TO ABIOTIC STIMULUS 222 1024 6.957e-10 3.764e-08
87 SYNAPTIC SIGNALING 110 424 9.131e-10 4.883e-08
88 POSITIVE REGULATION OF HYDROLASE ACTIVITY 200 905 9.9e-10 5.197e-08
89 MODULATION OF SYNAPTIC TRANSMISSION 85 301 9.941e-10 5.197e-08
90 MESENCHYME DEVELOPMENT 61 190 1.102e-09 5.695e-08
91 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 124 498 1.261e-09 6.45e-08
92 SENSORY ORGAN DEVELOPMENT 123 493 1.291e-09 6.53e-08
93 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 222 1036 2.03e-09 1.005e-07
94 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 222 1036 2.03e-09 1.005e-07
95 EMBRYONIC MORPHOGENESIS 131 539 2.243e-09 1.099e-07
96 MUSCLE STRUCTURE DEVELOPMENT 110 432 2.861e-09 1.372e-07
97 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 31 70 2.833e-09 1.372e-07
98 CELL CELL SIGNALING 173 767 2.911e-09 1.382e-07
99 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 353 1805 3.478e-09 1.635e-07
100 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 69 232 3.585e-09 1.668e-07
101 MESENCHYMAL CELL DIFFERENTIATION 47 134 3.703e-09 1.706e-07
102 POSITIVE REGULATION OF TRANSPORT 203 936 3.753e-09 1.712e-07
103 REGULATION OF KINASE ACTIVITY 174 776 4.148e-09 1.874e-07
104 POSITIVE REGULATION OF RESPONSE TO STIMULUS 373 1929 4.65e-09 2.08e-07
105 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 75 262 4.944e-09 2.191e-07
106 EPITHELIUM DEVELOPMENT 204 945 5.092e-09 2.225e-07
107 RESPONSE TO ORGANIC CYCLIC COMPOUND 199 917 5.117e-09 2.225e-07
108 TUBE DEVELOPMENT 132 552 5.743e-09 2.474e-07
109 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 132 554 7.279e-09 3.107e-07
110 NEURAL CREST CELL MIGRATION 25 51 7.43e-09 3.143e-07
111 AMEBOIDAL TYPE CELL MIGRATION 51 154 7.739e-09 3.244e-07
112 REGULATION OF DEVELOPMENTAL GROWTH 80 289 8.243e-09 3.424e-07
113 MORPHOGENESIS OF AN EPITHELIUM 102 400 9.872e-09 4.065e-07
114 NEURON PROJECTION GUIDANCE 62 205 1.086e-08 4.432e-07
115 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 67 229 1.243e-08 5.028e-07
116 NEGATIVE CHEMOTAXIS 21 39 1.383e-08 5.546e-07
117 CELL MOTILITY 182 835 1.692e-08 6.673e-07
118 LOCALIZATION OF CELL 182 835 1.692e-08 6.673e-07
119 CELLULAR RESPONSE TO PEPTIDE 76 274 1.757e-08 6.871e-07
120 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 296 1492 1.794e-08 6.955e-07
121 UROGENITAL SYSTEM DEVELOPMENT 81 299 1.919e-08 7.379e-07
122 REGULATION OF GROWTH 145 633 2.035e-08 7.761e-07
123 PROTEIN PHOSPHORYLATION 201 944 2.051e-08 7.761e-07
124 COGNITION 71 251 2.151e-08 8.072e-07
125 REGULATION OF BLOOD CIRCULATION 80 295 2.229e-08 8.296e-07
126 REGULATION OF METAL ION TRANSPORT 86 325 2.314e-08 8.546e-07
127 REGULATION OF CELL PROLIFERATION 296 1496 2.351e-08 8.613e-07
128 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 211 1004 2.683e-08 9.753e-07
129 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 76 278 3.437e-08 1.24e-06
130 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 354 1848 3.505e-08 1.254e-06
131 CEREBRAL CORTEX DEVELOPMENT 38 105 4.318e-08 1.534e-06
132 CAMERA TYPE EYE MORPHOGENESIS 37 101 4.478e-08 1.578e-06
133 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 52 166 4.534e-08 1.586e-06
134 NEGATIVE REGULATION OF CELL DIFFERENTIATION 139 609 5.037e-08 1.749e-06
135 NEURON MIGRATION 39 110 5.495e-08 1.894e-06
136 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 57 191 6.987e-08 2.391e-06
137 REGULATION OF CELLULAR LOCALIZATION 256 1277 7.124e-08 2.42e-06
138 HINDBRAIN DEVELOPMENT 45 137 7.577e-08 2.555e-06
139 REGULATION OF CELL SUBSTRATE ADHESION 53 173 7.702e-08 2.568e-06
140 TUBE MORPHOGENESIS 84 323 7.726e-08 2.568e-06
141 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 162 740 7.785e-08 2.569e-06
142 NEURAL CREST CELL DIFFERENTIATION 30 75 8.599e-08 2.818e-06
143 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 45 138 9.651e-08 3.14e-06
144 POSITIVE REGULATION OF MAPK CASCADE 112 470 9.889e-08 3.195e-06
145 REGULATION OF MAPK CASCADE 147 660 1.045e-07 3.353e-06
146 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 151 684 1.256e-07 4.002e-06
147 CELL CELL ADHESION 137 608 1.398e-07 4.396e-06
148 PALLIUM DEVELOPMENT 48 153 1.397e-07 4.396e-06
149 REGULATION OF ACTIN FILAMENT BASED PROCESS 81 312 1.417e-07 4.414e-06
150 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 230 1135 1.423e-07 4.414e-06
151 STEM CELL DIFFERENTIATION 56 190 1.443e-07 4.446e-06
152 NEGATIVE REGULATION OF TRANSPORT 109 458 1.568e-07 4.8e-06
153 EYE MORPHOGENESIS 44 136 1.72e-07 5.23e-06
154 SENSORY ORGAN MORPHOGENESIS 66 239 1.783e-07 5.386e-06
155 MULTICELLULAR ORGANISMAL SIGNALING 41 123 1.799e-07 5.401e-06
156 REGULATION OF CYTOSKELETON ORGANIZATION 117 502 1.817e-07 5.421e-06
157 REGULATION OF AXONOGENESIS 51 168 1.852e-07 5.489e-06
158 SKELETAL SYSTEM DEVELOPMENT 108 455 2.055e-07 6.053e-06
159 CELLULAR RESPONSE TO INSULIN STIMULUS 46 146 2.195e-07 6.423e-06
160 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 184 876 2.231e-07 6.489e-06
161 REGULATION OF HEART CONTRACTION 62 221 2.266e-07 6.549e-06
162 REGULATION OF ANATOMICAL STRUCTURE SIZE 111 472 2.311e-07 6.637e-06
163 RESPONSE TO PEPTIDE 98 404 2.557e-07 7.211e-06
164 RESPONSE TO OXYGEN LEVELS 80 311 2.552e-07 7.211e-06
165 HEART MORPHOGENESIS 60 212 2.532e-07 7.211e-06
166 CYTOSKELETON ORGANIZATION 177 838 2.589e-07 7.257e-06
167 MUSCLE CELL DIFFERENTIATION 65 237 2.89e-07 8.051e-06
168 NEGATIVE REGULATION OF CELL PROLIFERATION 142 643 2.914e-07 8.071e-06
169 ENSHEATHMENT OF NEURONS 33 91 3.099e-07 8.482e-06
170 AXON ENSHEATHMENT 33 91 3.099e-07 8.482e-06
171 EMBRYONIC ORGAN DEVELOPMENT 98 406 3.269e-07 8.895e-06
172 NEGATIVE REGULATION OF PHOSPHORYLATION 101 422 3.338e-07 9.03e-06
173 WOUND HEALING 110 470 3.375e-07 9.078e-06
174 NEGATIVE REGULATION OF CELL DEVELOPMENT 78 303 3.471e-07 9.283e-06
175 NEGATIVE REGULATION OF LOCOMOTION 70 263 3.578e-07 9.515e-06
176 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 123 541 3.674e-07 9.658e-06
177 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 123 541 3.674e-07 9.658e-06
178 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 45 144 3.841e-07 9.987e-06
179 PROTEIN LOCALIZATION 340 1805 3.842e-07 9.987e-06
180 POSITIVE REGULATION OF KINASE ACTIVITY 112 482 3.887e-07 1.005e-05
181 EMBRYONIC ORGAN MORPHOGENESIS 73 279 4.165e-07 1.071e-05
182 DENDRITE MORPHOGENESIS 20 42 4.302e-07 1.1e-05
183 MUSCLE TISSUE DEVELOPMENT 72 275 4.853e-07 1.234e-05
184 LONG TERM SYNAPTIC POTENTIATION 19 39 5.346e-07 1.345e-05
185 REGULATION OF TRANSMEMBRANE TRANSPORT 101 426 5.349e-07 1.345e-05
186 REGULATION OF TRANSFERASE ACTIVITY 194 946 6.042e-07 1.511e-05
187 RESPONSE TO STEROID HORMONE 114 497 6.129e-07 1.525e-05
188 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 108 465 6.388e-07 1.581e-05
189 PLASMA MEMBRANE ORGANIZATION 57 203 6.632e-07 1.633e-05
190 REGULATION OF CATABOLIC PROCESS 156 731 7.043e-07 1.725e-05
191 RHYTHMIC PROCESS 76 298 7.23e-07 1.761e-05
192 REGULATION OF DENDRITE DEVELOPMENT 39 120 7.41e-07 1.796e-05
193 REGULATION OF INTRACELLULAR TRANSPORT 136 621 8.433e-07 2.033e-05
194 DIGESTIVE SYSTEM DEVELOPMENT 45 148 9.058e-07 2.169e-05
195 RESPONSE TO LIPID 183 888 9.09e-07 2.169e-05
196 POSITIVE REGULATION OF LOCOMOTION 99 420 9.151e-07 2.172e-05
197 CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS 15 27 9.808e-07 2.317e-05
198 IN UTERO EMBRYONIC DEVELOPMENT 78 311 1.055e-06 2.48e-05
199 REGULATION OF SYNAPSE ORGANIZATION 37 113 1.151e-06 2.69e-05
200 REGULATION OF SYNAPTIC PLASTICITY 43 140 1.161e-06 2.702e-05
201 DENDRITE DEVELOPMENT 29 79 1.185e-06 2.722e-05
202 LEARNING 41 131 1.187e-06 2.722e-05
203 RETINA DEVELOPMENT IN CAMERA TYPE EYE 41 131 1.187e-06 2.722e-05
204 DEVELOPMENTAL GROWTH 82 333 1.252e-06 2.857e-05
205 REGULATION OF CELL GROWTH 93 391 1.283e-06 2.912e-05
206 MUSCLE SYSTEM PROCESS 72 282 1.34e-06 3.026e-05
207 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 36 110 1.618e-06 3.637e-05
208 SMOOTHENED SIGNALING PATHWAY 27 72 1.696e-06 3.793e-05
209 REGULATION OF CELL JUNCTION ASSEMBLY 26 68 1.711e-06 3.81e-05
210 FAT CELL DIFFERENTIATION 35 106 1.782e-06 3.948e-05
211 REGULATION OF CELL DEATH 280 1472 2.002e-06 4.415e-05
212 REGULATION OF EPITHELIAL CELL PROLIFERATION 72 285 2.033e-06 4.441e-05
213 PALATE DEVELOPMENT 30 85 2.028e-06 4.441e-05
214 CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS 13 22 2.049e-06 4.455e-05
215 RESPONSE TO INSULIN 56 205 2.135e-06 4.62e-05
216 CELLULAR RESPONSE TO OXYGEN LEVELS 43 143 2.171e-06 4.654e-05
217 RESPONSE TO MECHANICAL STIMULUS 57 210 2.166e-06 4.654e-05
218 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 47 162 2.285e-06 4.877e-05
219 ACTION POTENTIAL 32 94 2.315e-06 4.919e-05
220 RESPONSE TO INORGANIC SUBSTANCE 108 479 2.805e-06 5.933e-05
221 REGULATION OF CELL ADHESION 135 629 2.873e-06 6.049e-05
222 REGULATION OF HOMEOSTATIC PROCESS 102 447 3.01e-06 6.309e-05
223 REGULATION OF OSSIFICATION 50 178 3.095e-06 6.457e-05
224 MEMBRANE ORGANIZATION 182 899 3.169e-06 6.583e-05
225 OVULATION CYCLE 36 113 3.285e-06 6.69e-05
226 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 100 437 3.292e-06 6.69e-05
227 FOREBRAIN CELL MIGRATION 24 62 3.293e-06 6.69e-05
228 RESPONSE TO GROWTH FACTOR 107 475 3.254e-06 6.69e-05
229 EXTRACELLULAR STRUCTURE ORGANIZATION 75 304 3.247e-06 6.69e-05
230 REGULATION OF TRANSPORTER ACTIVITY 54 198 3.392e-06 6.862e-05
231 GLIAL CELL DIFFERENTIATION 41 136 3.447e-06 6.944e-05
232 METENCEPHALON DEVELOPMENT 33 100 3.527e-06 7.075e-05
233 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 69 274 3.705e-06 7.399e-05
234 ION TRANSPORT 243 1262 3.99e-06 7.933e-05
235 PLATELET ACTIVATION 42 142 4.519e-06 8.947e-05
236 REGULATION OF VESICLE MEDIATED TRANSPORT 104 462 4.591e-06 9.051e-05
237 REGULATION OF ORGANELLE ORGANIZATION 228 1178 5.538e-06 0.0001087
238 REGULATION OF DENDRITIC SPINE MORPHOGENESIS 15 30 5.634e-06 0.0001101
239 DIGESTIVE TRACT MORPHOGENESIS 20 48 5.734e-06 0.0001116
240 GROWTH 94 410 5.899e-06 0.0001144
241 NERVE DEVELOPMENT 25 68 6.149e-06 0.0001187
242 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 359 1977 6.671e-06 0.0001283
243 EXCITATORY POSTSYNAPTIC POTENTIAL 14 27 6.714e-06 0.0001286
244 ACTIN FILAMENT BASED PROCESS 101 450 7.159e-06 0.0001365
245 ENDOTHELIUM DEVELOPMENT 30 90 7.676e-06 0.0001452
246 REGULATION OF CELL MATRIX ADHESION 30 90 7.676e-06 0.0001452
247 RETINA MORPHOGENESIS IN CAMERA TYPE EYE 19 45 7.755e-06 0.0001461
248 REGULATION OF BLOOD PRESSURE 47 169 8.084e-06 0.0001517
249 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 20 49 8.35e-06 0.000156
250 GLIOGENESIS 48 175 9.791e-06 0.0001815
251 CELL PROLIFERATION 140 672 9.77e-06 0.0001815
252 PROTEIN LOCALIZATION TO CELL PERIPHERY 43 151 1.013e-05 0.0001871
253 REGULATION OF DENDRITE MORPHOGENESIS 26 74 1.049e-05 0.0001925
254 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 44 156 1.051e-05 0.0001925
255 POSITIVE REGULATION OF CELL DEATH 128 605 1.079e-05 0.0001969
256 WNT SIGNALING PATHWAY 82 351 1.09e-05 0.0001981
257 POSITIVE REGULATION OF ION TRANSPORT 60 236 1.131e-05 0.0002047
258 NEURONAL ACTION POTENTIAL 14 28 1.16e-05 0.0002093
259 REGULATION OF POTASSIUM ION TRANSPORT 28 83 1.181e-05 0.0002123
260 RESPONSE TO MONOAMINE 16 35 1.19e-05 0.000213
261 REGULATION OF ADHERENS JUNCTION ORGANIZATION 20 50 1.2e-05 0.0002138
262 NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION 23 62 1.205e-05 0.000214
263 MICROTUBULE BASED PROCESS 113 522 1.216e-05 0.0002151
264 NEGATIVE REGULATION OF GENE EXPRESSION 278 1493 1.227e-05 0.0002155
265 TRANSMISSION OF NERVE IMPULSE 21 54 1.227e-05 0.0002155
266 ARTERY DEVELOPMENT 26 75 1.382e-05 0.0002411
267 DOPAMINE METABOLIC PROCESS 13 25 1.385e-05 0.0002411
268 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 54 207 1.389e-05 0.0002411
269 CHEMICAL HOMEOSTASIS 174 874 1.441e-05 0.0002493
270 HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 43 153 1.45e-05 0.0002499
271 NEGATIVE REGULATION OF CELL ADHESION 57 223 1.562e-05 0.0002683
272 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 32 102 1.606e-05 0.0002747
273 TAXIS 102 464 1.633e-05 0.0002782
274 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 10 16 1.638e-05 0.0002782
275 VASCULOGENESIS 22 59 1.686e-05 0.0002853
276 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 103 470 1.705e-05 0.0002874
277 REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 21 55 1.711e-05 0.0002874
278 SINGLE ORGANISM CELL ADHESION 101 459 1.718e-05 0.0002876
279 ENDOMEMBRANE SYSTEM ORGANIZATION 102 465 1.794e-05 0.0002992
280 CELL SUBSTRATE ADHESION 45 164 1.809e-05 0.0002996
281 PHOSPHORYLATION 233 1228 1.803e-05 0.0002996
282 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 36 121 1.828e-05 0.0003016
283 REGULATION OF OSTEOBLAST DIFFERENTIATION 34 112 1.935e-05 0.0003182
284 ENDOTHELIAL CELL DIFFERENTIATION 25 72 1.948e-05 0.0003191
285 MUSCLE ORGAN DEVELOPMENT 67 277 2.103e-05 0.0003425
286 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 91 406 2.105e-05 0.0003425
287 REGULATION OF BODY FLUID LEVELS 109 506 2.148e-05 0.0003483
288 NEGATIVE REGULATION OF CELL GROWTH 46 170 2.166e-05 0.0003499
289 POSITIVE REGULATION OF DENDRITE DEVELOPMENT 23 64 2.198e-05 0.0003539
290 REGULATION OF GLUCOSE IMPORT 22 60 2.294e-05 0.0003681
291 REGENERATION 44 161 2.482e-05 0.0003969
292 CELLULAR MACROMOLECULE LOCALIZATION 233 1234 2.521e-05 0.0004017
293 RESPONSE TO CORTICOSTEROID 47 176 2.562e-05 0.0004028
294 HOMEOSTATIC PROCESS 250 1337 2.556e-05 0.0004028
295 REGULATION OF ION HOMEOSTASIS 52 201 2.538e-05 0.0004028
296 REGULATION OF ORGAN MORPHOGENESIS 60 242 2.55e-05 0.0004028
297 POSITIVE REGULATION OF AXONOGENESIS 24 69 2.746e-05 0.0004303
298 REGULATION OF CYTOPLASMIC TRANSPORT 104 481 2.801e-05 0.0004374
299 MUSCLE CELL DEVELOPMENT 37 128 2.853e-05 0.0004439
300 INNERVATION 12 23 2.862e-05 0.0004439
301 REGULATION OF EMBRYONIC DEVELOPMENT 34 114 2.916e-05 0.0004508
302 REGULATION OF PROTEIN LOCALIZATION 185 950 2.993e-05 0.0004612
303 REGULATION OF VASCULATURE DEVELOPMENT 58 233 3.048e-05 0.000468
304 AORTA DEVELOPMENT 17 41 3.087e-05 0.0004725
305 NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY 14 30 3.142e-05 0.0004794
306 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 40 143 3.194e-05 0.0004857
307 CYCLIC NUCLEOTIDE METABOLIC PROCESS 21 57 3.22e-05 0.000488
308 REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY 9 14 3.235e-05 0.0004887
309 SMOOTH MUSCLE CONTRACTION 18 45 3.25e-05 0.0004893
310 MELANOCYTE DIFFERENTIATION 11 20 3.26e-05 0.0004893
311 VESICLE MEDIATED TRANSPORT 233 1239 3.316e-05 0.0004929
312 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 20 53 3.3e-05 0.0004929
313 GLOMERULUS DEVELOPMENT 19 49 3.315e-05 0.0004929
314 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 53 208 3.342e-05 0.0004953
315 STRIATED MUSCLE CELL DIFFERENTIATION 46 173 3.491e-05 0.0005156
316 NEPHRON DEVELOPMENT 34 115 3.56e-05 0.0005242
317 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 24 70 3.599e-05 0.0005283
318 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 15 34 3.753e-05 0.0005457
319 REGULATION OF MESENCHYMAL CELL PROLIFERATION 15 34 3.753e-05 0.0005457
320 CAMP METABOLIC PROCESS 15 34 3.753e-05 0.0005457
321 REGULATION OF GLUCOSE METABOLIC PROCESS 32 106 3.793e-05 0.0005498
322 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 52 204 3.903e-05 0.000564
323 REGULATION OF ENDOCYTOSIS 51 199 3.954e-05 0.0005686
324 PATTERN SPECIFICATION PROCESS 92 418 3.959e-05 0.0005686
325 CELLULAR RESPONSE TO LIPID 99 457 3.99e-05 0.0005689
326 OVULATION CYCLE PROCESS 28 88 3.998e-05 0.0005689
327 REGULATION OF STEM CELL PROLIFERATION 28 88 3.998e-05 0.0005689
328 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 278 1517 4.111e-05 0.0005822
329 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 127 616 4.117e-05 0.0005822
330 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 22 62 4.129e-05 0.0005823
331 RESPONSE TO RADIATION 91 413 4.165e-05 0.0005854
332 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 16 38 4.197e-05 0.0005882
333 SECRETION 122 588 4.326e-05 0.0006033
334 FEMALE SEX DIFFERENTIATION 34 116 4.33e-05 0.0006033
335 REPRODUCTIVE SYSTEM DEVELOPMENT 90 408 4.38e-05 0.0006083
336 AUTONOMIC NERVOUS SYSTEM DEVELOPMENT 17 42 4.476e-05 0.0006181
337 POSITIVE REGULATION OF OSSIFICATION 27 84 4.465e-05 0.0006181
338 NEGATIVE REGULATION OF GROWTH 58 236 4.512e-05 0.0006211
339 MEMORY 30 98 4.9e-05 0.0006725
340 HEMOSTASIS 72 311 4.977e-05 0.0006811
341 CELL PROJECTION ASSEMBLY 63 264 5.606e-05 0.0007649
342 RESPONSE TO LIGHT STIMULUS 66 280 5.652e-05 0.000769
343 LIPID TRANSLOCATION 11 21 5.933e-05 0.0008048
344 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 30 99 6.048e-05 0.0008158
345 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 30 99 6.048e-05 0.0008158
346 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 179 926 6.116e-05 0.000821
347 CRANIAL SKELETAL SYSTEM DEVELOPMENT 20 55 6.123e-05 0.000821
348 RESPONSE TO ALCOHOL 81 362 6.193e-05 0.000828
349 PHENOL CONTAINING COMPOUND METABOLIC PROCESS 26 81 6.297e-05 0.0008359
350 POSITIVE REGULATION OF CELL PROLIFERATION 160 814 6.284e-05 0.0008359
351 REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 8 12 6.305e-05 0.0008359
352 REGULATION OF CELL SIZE 45 172 6.445e-05 0.0008492
353 MORPHOGENESIS OF A BRANCHING STRUCTURE 44 167 6.46e-05 0.0008492
354 REGULATION OF FATTY ACID OXIDATION 13 28 6.453e-05 0.0008492
355 ORGAN GROWTH 23 68 6.617e-05 0.0008673
356 REGULATION OF COLLATERAL SPROUTING 10 18 6.736e-05 0.0008804
357 DEVELOPMENTAL CELL GROWTH 25 77 7.01e-05 0.0009137
358 SECRETION BY CELL 103 486 7.053e-05 0.0009167
359 REGULATION OF PHOSPHOLIPASE ACTIVITY 22 64 7.181e-05 0.0009308
360 VASCULAR PROCESS IN CIRCULATORY SYSTEM 43 163 7.535e-05 0.0009739
361 REGULATION OF CALCIUM ION TRANSPORT 52 209 7.742e-05 0.0009979
362 INOSITOL LIPID MEDIATED SIGNALING 35 124 7.921e-05 0.001018
363 MEMBRANE ASSEMBLY 12 25 8.252e-05 0.001049
364 REGULATION OF DENDRITIC SPINE DEVELOPMENT 20 56 8.213e-05 0.001049
365 CONNECTIVE TISSUE DEVELOPMENT 49 194 8.224e-05 0.001049
366 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM 12 25 8.252e-05 0.001049
367 NEGATIVE REGULATION OF CELL DEATH 169 872 8.498e-05 0.001074
368 CELLULAR RESPONSE TO OXIDATIVE STRESS 47 184 8.482e-05 0.001074
369 RESPONSE TO METAL ION 75 333 9.116e-05 0.001146
370 REGULATION OF EXTENT OF CELL GROWTH 30 101 9.101e-05 0.001146
371 ACTIVATION OF PROTEIN KINASE ACTIVITY 65 279 9.26e-05 0.001161
372 REGULATION OF HORMONE LEVELS 101 478 9.309e-05 0.001164
373 ADULT BEHAVIOR 37 135 9.905e-05 0.001236
374 CARDIAC MUSCLE TISSUE DEVELOPMENT 38 140 0.0001005 0.001251
375 POSITIVE REGULATION OF SYNAPSE ASSEMBLY 21 61 0.0001015 0.001256
376 POSITIVE REGULATION OF STEM CELL PROLIFERATION 21 61 0.0001015 0.001256
377 SECOND MESSENGER MEDIATED SIGNALING 42 160 0.0001024 0.001264
378 GLAND DEVELOPMENT 86 395 0.0001035 0.001274
379 REGULATION OF SYNAPSE ASSEMBLY 25 79 0.000112 0.001375
380 LOCOMOTORY BEHAVIOR 46 181 0.0001141 0.001398
381 RESPONSE TO OXIDATIVE STRESS 78 352 0.0001172 0.001432
382 POSITIVE REGULATION OF MAP KINASE ACTIVITY 51 207 0.0001177 0.001433
383 REGULATION OF EPITHELIAL CELL MIGRATION 43 166 0.0001183 0.001437
384 REGULATION OF MEMBRANE LIPID DISTRIBUTION 15 37 0.0001222 0.001481
385 REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION 10 19 0.0001234 0.001481
386 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 26 84 0.0001242 0.001481
387 TISSUE MIGRATION 26 84 0.0001242 0.001481
388 NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 10 19 0.0001234 0.001481
389 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 122 602 0.0001244 0.001481
390 REGULATION OF LONG TERM SYNAPTIC POTENTIATION 10 19 0.0001234 0.001481
391 RESPIRATORY SYSTEM DEVELOPMENT 49 197 0.0001235 0.001481
392 SPROUTING ANGIOGENESIS 17 45 0.0001248 0.001481
393 RESPONSE TO EXTERNAL STIMULUS 323 1821 0.0001307 0.001547
394 RESPONSE TO KETONE 46 182 0.0001312 0.00155
395 REGULATION OF CIRCADIAN RHYTHM 30 103 0.0001347 0.001587
396 REGULATED EXOCYTOSIS 54 224 0.0001388 0.001631
397 NEURON CELL CELL ADHESION 9 16 0.0001395 0.001635
398 REGULATION OF WNT SIGNALING PATHWAY 70 310 0.0001414 0.001653
399 REGULATION OF VASCULOGENESIS 8 13 0.0001427 0.001664
400 CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS 58 246 0.0001531 0.001781
401 CARDIAC SEPTUM DEVELOPMENT 26 85 0.0001541 0.001788
402 REGULATION OF NEURON MIGRATION 13 30 0.0001546 0.001789
403 LIPID PHOSPHORYLATION 29 99 0.0001549 0.001789
404 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 30 104 0.000163 0.001877
405 REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 18 50 0.0001637 0.001881
406 REGULATION OF NEURON DEATH 59 252 0.0001652 0.001893
407 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 17 46 0.0001709 0.001954
408 CATECHOLAMINE METABOLIC PROCESS 16 42 0.000175 0.001986
409 POSITIVE REGULATION OF GLUCOSE TRANSPORT 16 42 0.000175 0.001986
410 CATECHOL CONTAINING COMPOUND METABOLIC PROCESS 16 42 0.000175 0.001986
411 POSITIVE REGULATION OF ENDOCYTOSIS 32 114 0.0001757 0.001989
412 REGULATION OF MUSCLE SYSTEM PROCESS 48 195 0.0001878 0.002121
413 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 40 154 0.0001885 0.002124
414 CARDIAC CHAMBER DEVELOPMENT 38 144 0.00019 0.002128
415 AGING 61 264 0.0001902 0.002128
416 REGULATION OF HEART RATE 26 86 0.0001902 0.002128
417 REGULATION OF NEUROTRANSMITTER LEVELS 47 190 0.0001927 0.00215
418 SINGLE ORGANISM CELLULAR LOCALIZATION 171 898 0.0001956 0.002177
419 ACTOMYOSIN STRUCTURE ORGANIZATION 24 77 0.0001978 0.002191
420 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 24 77 0.0001978 0.002191
421 CELL ACTIVATION 115 568 0.0001997 0.002207
422 CELL DEATH 188 1001 0.0002045 0.002255
423 CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 12 27 0.0002069 0.002271
424 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 12 27 0.0002069 0.002271
425 MUSCLE CONTRACTION 55 233 0.0002162 0.002368
426 NEGATIVE REGULATION OF CHEMOTAXIS 18 51 0.0002184 0.002385
427 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 123 616 0.0002219 0.002418
428 MICROTUBULE CYTOSKELETON ORGANIZATION 76 348 0.0002294 0.002494
429 REGULATION OF SYNAPTIC VESICLE TRANSPORT 13 31 0.0002304 0.002499
430 REGULATION OF CELLULAR COMPONENT SIZE 74 337 0.0002315 0.002505
431 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 52 218 0.0002412 0.002598
432 CEREBRAL CORTEX CELL MIGRATION 16 43 0.0002408 0.002598
433 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 32 116 0.0002489 0.002666
434 REGULATION OF NEURON APOPTOTIC PROCESS 47 192 0.0002498 0.002666
435 MULTI MULTICELLULAR ORGANISM PROCESS 51 213 0.0002497 0.002666
436 CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT 32 116 0.0002489 0.002666
437 BONE DEVELOPMENT 40 156 0.0002525 0.002683
438 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 40 156 0.0002525 0.002683
439 REGULATION OF DOPAMINE METABOLIC PROCESS 9 17 0.0002576 0.002718
440 CYCLIC NUCLEOTIDE CATABOLIC PROCESS 9 17 0.0002576 0.002718
441 REGULATION OF CATECHOLAMINE METABOLIC PROCESS 9 17 0.0002576 0.002718
442 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 19 56 0.0002657 0.002791
443 OUTFLOW TRACT MORPHOGENESIS 19 56 0.0002657 0.002791
444 POST GOLGI VESICLE MEDIATED TRANSPORT 25 83 0.0002671 0.002799
445 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 65 289 0.0002692 0.002815
446 AXON REGENERATION 11 24 0.0002735 0.002841
447 IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY 11 24 0.0002735 0.002841
448 RENAL SYSTEM PROCESS 29 102 0.0002728 0.002841
449 REGULATION OF HORMONE SECRETION 60 262 0.000275 0.002849
450 POSITIVE REGULATION OF CATABOLIC PROCESS 84 395 0.0002797 0.002892
451 REGULATION OF CATION CHANNEL ACTIVITY 26 88 0.0002857 0.002948
452 CAMP CATABOLIC PROCESS 8 14 0.0002897 0.002982
453 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 32 117 0.0002948 0.003028
454 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 33 122 0.0002987 0.003061
455 RESPONSE TO AXON INJURY 17 48 0.0003093 0.003163
456 CYTOKINESIS 25 84 0.0003277 0.003336
457 REPRODUCTION 235 1297 0.0003273 0.003336
458 NEUROMUSCULAR JUNCTION DEVELOPMENT 14 36 0.0003433 0.003465
459 RESPONSE TO ACID CHEMICAL 70 319 0.0003431 0.003465
460 REGULATION OF MAP KINASE ACTIVITY 70 319 0.0003431 0.003465
461 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 45 184 0.0003415 0.003465
462 REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY 26 89 0.0003477 0.003502
463 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 35 133 0.0003528 0.003546
464 EPITHELIAL CELL DIFFERENTIATION 101 495 0.0003563 0.003573
465 INSULIN RECEPTOR SIGNALING PATHWAY 24 80 0.0003752 0.003754
466 REGULATION OF JNK CASCADE 40 159 0.0003853 0.003847
467 SEX DIFFERENTIATION 60 266 0.0004183 0.004168
468 GLUCOSE HOMEOSTASIS 42 170 0.0004215 0.004173
469 MIDBRAIN DEVELOPMENT 26 90 0.0004212 0.004173
470 CARBOHYDRATE HOMEOSTASIS 42 170 0.0004215 0.004173
471 CILIUM MORPHOGENESIS 49 207 0.0004323 0.004271
472 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 9 18 0.0004479 0.004397
473 RETINAL GANGLION CELL AXON GUIDANCE 9 18 0.0004479 0.004397
474 SMOOTH MUSCLE TISSUE DEVELOPMENT 9 18 0.0004479 0.004397
475 GLUTAMATE RECEPTOR SIGNALING PATHWAY 15 41 0.0004625 0.004531
476 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 47 197 0.0004648 0.004544
477 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 50 213 0.0004674 0.00456
478 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 35 135 0.0004771 0.004613
479 CORONARY VASCULATURE DEVELOPMENT 14 37 0.0004778 0.004613
480 MATING 14 37 0.0004778 0.004613
481 AXON EXTENSION 14 37 0.0004778 0.004613
482 CELL GROWTH 35 135 0.0004771 0.004613
483 NEURON PROJECTION REGENERATION 13 33 0.00048 0.004618
484 NEGATIVE REGULATION OF NEURON DEATH 42 171 0.0004803 0.004618
485 REGULATION OF RESPONSE TO WOUNDING 86 413 0.0004855 0.004658
486 REGULATION OF AMINE TRANSPORT 22 72 0.0004887 0.004679
487 REGULATION OF SECRETION 135 699 0.0004928 0.004708
488 REGULATION OF CELLULAR PROTEIN LOCALIZATION 110 552 0.0005013 0.00478
489 RESPONSE TO DRUG 89 431 0.0005196 0.004944
490 IMMUNE SYSTEM DEVELOPMENT 115 582 0.000527 0.004994
491 CARDIOCYTE DIFFERENTIATION 27 96 0.0005261 0.004994
492 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 139 724 0.0005298 0.005011
493 NEURAL RETINA DEVELOPMENT 17 50 0.0005356 0.005055
494 NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 8 15 0.0005405 0.005091
495 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 46 193 0.000543 0.005094
496 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 75 352 0.0005424 0.005094
497 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 45 188 0.0005624 0.005265
498 RETINA LAYER FORMATION 10 22 0.000565 0.005268
499 SUBPALLIUM DEVELOPMENT 10 22 0.000565 0.005268
500 CYCLIC NUCLEOTIDE MEDIATED SIGNALING 16 46 0.0005812 0.005409
501 ASSOCIATIVE LEARNING 22 73 0.0006034 0.005582
502 RESPONSE TO METHYLMERCURY 7 12 0.0006035 0.005582
503 VASCULAR SMOOTH MUSCLE CONTRACTION 7 12 0.0006035 0.005582
504 ANTERIOR POSTERIOR PATTERN SPECIFICATION 46 194 0.0006118 0.005648
505 REGULATION OF CELLULAR RESPONSE TO STRESS 133 691 0.0006229 0.005739
506 ESTABLISHMENT OF LOCALIZATION BY MOVEMENT ALONG MICROTUBULE 27 97 0.000628 0.005775
507 REGULATION OF NEUROTRANSMITTER TRANSPORT 20 64 0.0006296 0.005778
508 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 11 26 0.0006369 0.005822
509 MICROTUBULE BASED MOVEMENT 48 205 0.0006365 0.005822
510 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 23 78 0.0006446 0.005881
511 PLATELET DEGRANULATION 29 107 0.0006504 0.005922
512 POSITIVE REGULATION OF POTASSIUM ION TRANSPORT 14 38 0.0006547 0.005939
513 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 14 38 0.0006547 0.005939
514 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 50 216 0.000656 0.005939
515 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 31 117 0.0006577 0.005942
516 MEMBRANE BIOGENESIS 12 30 0.0006699 0.006018
517 NEGATIVE REGULATION OF CELL MATRIX ADHESION 12 30 0.0006699 0.006018
518 MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 12 30 0.0006699 0.006018
519 FOREBRAIN NEURON DEVELOPMENT 13 34 0.000673 0.006034
520 PROTEOGLYCAN METABOLIC PROCESS 24 83 0.0006792 0.006066
521 REGULATION OF LIPASE ACTIVITY 24 83 0.0006792 0.006066
522 REGULATION OF ERK1 AND ERK2 CASCADE 54 238 0.0006813 0.006073
523 TRANSMEMBRANE TRANSPORT 200 1098 0.0006852 0.006096
524 PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 21 69 0.0006892 0.006119
525 REGULATION OF NEUROTRANSMITTER SECRETION 17 51 0.0006943 0.006141
526 ARTERY MORPHOGENESIS 17 51 0.0006943 0.006141
527 ESTABLISHMENT OF LOCALIZATION IN CELL 293 1676 0.0007094 0.006263
528 STEM CELL PROLIFERATION 19 60 0.0007106 0.006263
529 PROTEIN DEPHOSPHORYLATION 45 190 0.0007147 0.006275
530 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 45 190 0.0007147 0.006275
531 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 26 93 0.00073 0.006397
532 REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 9 19 0.0007399 0.00646
533 FIBRIL ORGANIZATION 9 19 0.0007399 0.00646
534 CELL JUNCTION ORGANIZATION 44 185 0.0007415 0.006461
535 REGULATION OF MUSCLE TISSUE DEVELOPMENT 28 103 0.0007586 0.006598
536 NEGATIVE REGULATION OF KINASE ACTIVITY 56 250 0.0007613 0.006609
537 REGULATION OF CHEMOTAXIS 43 180 0.0007685 0.006659
538 NEGATIVE REGULATION OF AXONOGENESIS 20 65 0.000785 0.006789
539 CRANIAL NERVE DEVELOPMENT 15 43 0.0008267 0.007123
540 REGULATION OF CATECHOLAMINE SECRETION 15 43 0.0008267 0.007123
541 PEPTIDYL TYROSINE MODIFICATION 44 186 0.000835 0.007182
542 ANION TRANSPORT 101 507 0.0008407 0.007218
543 REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING 10 23 0.0008682 0.007426
544 REGULATION OF METANEPHROS DEVELOPMENT 10 23 0.0008682 0.007426
545 CELL JUNCTION ASSEMBLY 33 129 0.0008758 0.007478
546 REGULATION OF PHOSPHOLIPASE C ACTIVITY 14 39 0.0008841 0.007534
547 PROTEIN AUTOPHOSPHORYLATION 45 192 0.0009025 0.007677
548 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 22 75 0.0009042 0.007677
549 NEURON APOPTOTIC PROCESS 13 35 0.0009274 0.007832
550 POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT 13 35 0.0009274 0.007832
551 EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 13 35 0.0009274 0.007832
552 REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 11 27 0.0009326 0.007861
553 NEGATIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 8 16 0.0009416 0.007866
554 NEGATIVE REGULATION OF STRESS FIBER ASSEMBLY 8 16 0.0009416 0.007866
555 RESPONSE TO EPINEPHRINE 8 16 0.0009416 0.007866
556 STRIATUM DEVELOPMENT 8 16 0.0009416 0.007866
557 REGULATION OF FATTY ACID BETA OXIDATION 8 16 0.0009416 0.007866
558 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 197 1087 0.0009666 0.00806
559 REGULATION OF MULTICELLULAR ORGANISM GROWTH 20 66 0.0009722 0.008078
560 REGULATION OF CARDIAC CONDUCTION 20 66 0.0009722 0.008078
561 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 53 236 0.0009741 0.008079
562 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 34 135 0.0009923 0.008215
563 AXIS SPECIFICATION 25 90 0.001012 0.008352
564 ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 25 90 0.001012 0.008352
565 KIDNEY EPITHELIUM DEVELOPMENT 32 125 0.001026 0.008449
566 REGULATION OF GLUCOSE TRANSPORT 27 100 0.001044 0.008571
567 LIMBIC SYSTEM DEVELOPMENT 27 100 0.001044 0.008571
568 REGULATION OF CALCIUM MEDIATED SIGNALING 22 76 0.001098 0.008973
569 POSITIVE REGULATION OF TRANSPORTER ACTIVITY 22 76 0.001098 0.008973
570 RESPONSE TO EXTRACELLULAR STIMULUS 89 441 0.001099 0.008973
571 LIPID MODIFICATION 48 210 0.001108 0.009032
572 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 17 53 0.001134 0.009211
573 REGULATION OF MICROTUBULE BASED PROCESS 54 243 0.001134 0.009211
574 EXTRACELLULAR FIBRIL ORGANIZATION 7 13 0.001141 0.00925
575 ION TRANSMEMBRANE TRANSPORT 153 822 0.001146 0.009273
576 HINDBRAIN MORPHOGENESIS 14 40 0.001177 0.009512
577 POSITIVE REGULATION OF GROWTH 53 238 0.001192 0.00961
578 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 48 211 0.001233 0.009928
NumGOOverlapSizeP ValueAdj. P Value
1 ENZYME BINDING 374 1737 1.276e-15 1.185e-12
2 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 269 1199 1.655e-13 7.688e-11
3 CYTOSKELETAL PROTEIN BINDING 192 819 1.188e-11 3.68e-09
4 KINASE BINDING 149 606 7.195e-11 1.337e-08
5 MACROMOLECULAR COMPLEX BINDING 293 1399 6.218e-11 1.337e-08
6 PROTEIN COMPLEX BINDING 208 935 2.466e-10 3.338e-08
7 MOLECULAR FUNCTION REGULATOR 282 1353 2.515e-10 3.338e-08
8 REGULATORY REGION NUCLEIC ACID BINDING 183 818 1.959e-09 2.274e-07
9 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 147 629 4.053e-09 4.184e-07
10 CELL ADHESION MOLECULE BINDING 58 186 9.366e-09 8.701e-07
11 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 33 81 1.148e-08 9.693e-07
12 KINASE ACTIVITY 183 842 1.926e-08 1.376e-06
13 GROWTH FACTOR BINDING 43 123 1.883e-08 1.376e-06
14 PROTEIN KINASE ACTIVITY 146 640 2.4e-08 1.593e-06
15 PROTEIN HOMODIMERIZATION ACTIVITY 159 722 6.872e-08 4.256e-06
16 CALCIUM ION BINDING 154 697 8.894e-08 5.164e-06
17 RECEPTOR BINDING 289 1476 9.651e-08 5.274e-06
18 TRANSFORMING GROWTH FACTOR BETA BINDING 12 16 1.062e-07 5.48e-06
19 ENZYME ACTIVATOR ACTIVITY 111 471 2.061e-07 8.705e-06
20 NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 84 329 1.83e-07 8.705e-06
21 IDENTICAL PROTEIN BINDING 242 1209 1.89e-07 8.705e-06
22 RIBONUCLEOTIDE BINDING 351 1860 2.006e-07 8.705e-06
23 ACTIN BINDING 96 393 2.395e-07 9.674e-06
24 PROTEIN DIMERIZATION ACTIVITY 230 1149 3.852e-07 1.491e-05
25 GLYCOSAMINOGLYCAN BINDING 58 205 4.031e-07 1.498e-05
26 DOUBLE STRANDED DNA BINDING 162 764 6.521e-07 2.33e-05
27 SULFUR COMPOUND BINDING 63 234 8.802e-07 3.028e-05
28 MICROTUBULE BINDING 56 201 1.086e-06 3.564e-05
29 PROTEIN DOMAIN SPECIFIC BINDING 136 624 1.112e-06 3.564e-05
30 TUBULIN BINDING 70 273 1.583e-06 4.743e-05
31 ENZYME REGULATOR ACTIVITY 194 959 1.576e-06 4.743e-05
32 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 198 992 3.112e-06 9.033e-05
33 INTEGRIN BINDING 34 105 4.068e-06 0.0001145
34 HEPARIN BINDING 45 157 5.289e-06 0.0001436
35 ADENYL NUCLEOTIDE BINDING 284 1514 5.41e-06 0.0001436
36 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 24 64 6.307e-06 0.0001628
37 ZINC ION BINDING 223 1155 8.363e-06 0.00021
38 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 73 303 1.065e-05 0.0002604
39 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 39 133 1.219e-05 0.0002904
40 PROTEIN SERINE THREONINE KINASE ACTIVITY 99 445 1.293e-05 0.0003004
41 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 58 228 1.541e-05 0.0003492
42 SMAD BINDING 25 72 1.948e-05 0.0004308
43 TRANSITION METAL ION BINDING 261 1400 2.101e-05 0.0004538
44 PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 101 464 2.736e-05 0.0005672
45 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 123 588 2.748e-05 0.0005672
46 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING 20 53 3.3e-05 0.0006522
47 TRANSLATION REPRESSOR ACTIVITY 11 20 3.26e-05 0.0006522
48 GATED CHANNEL ACTIVITY 75 325 3.931e-05 0.0007608
49 SH3 DOMAIN BINDING 34 116 4.33e-05 0.000821
50 PROTEIN TYROSINE KINASE BINDING 20 54 4.518e-05 0.0008395
51 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 75 328 5.425e-05 0.0009691
52 SEQUENCE SPECIFIC DNA BINDING 198 1037 5.325e-05 0.0009691
53 X3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY 9 15 7.025e-05 0.001216
54 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 27 86 7.069e-05 0.001216
55 BINDING BRIDGING 45 173 7.484e-05 0.001264
56 CYCLIC NUCLEOTIDE BINDING 15 36 8.406e-05 0.00137
57 RNA POLYMERASE II TRANSCRIPTION COACTIVATOR ACTIVITY 15 36 8.406e-05 0.00137
58 PHOSPHATIDYLINOSITOL BINDING 50 200 9.246e-05 0.001481
59 TRANSCRIPTION FACTOR BINDING 109 524 9.721e-05 0.001531
60 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 23 70 0.0001098 0.0017
61 PHOSPHOLIPASE BINDING 10 19 0.0001234 0.001879
62 CATION CHANNEL ACTIVITY 68 298 0.0001258 0.001885
63 RECEPTOR SIGNALING PROTEIN ACTIVITY 44 172 0.0001353 0.001995
64 POTASSIUM CHANNEL REGULATOR ACTIVITY 17 46 0.0001709 0.002481
65 PHOSPHORIC ESTER HYDROLASE ACTIVITY 80 368 0.0001864 0.002664
66 CHEMOREPELLENT ACTIVITY 12 27 0.0002069 0.002913
67 EXTRACELLULAR GLUTAMATE GATED ION CHANNEL ACTIVITY 10 20 0.0002142 0.00297
68 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 29 101 0.0002268 0.003099
69 CYTOKINE BINDING 27 92 0.0002487 0.003209
70 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 16 43 0.0002408 0.003209
71 ION CHANNEL BINDING 31 111 0.000243 0.003209
72 PHOSPHOLIPID BINDING 78 360 0.0002484 0.003209
73 CHANNEL REGULATOR ACTIVITY 35 131 0.0002581 0.003241
74 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY 9 17 0.0002576 0.003241
75 PHOSPHOLIPID TRANSPORTER ACTIVITY 17 48 0.0003093 0.003831
76 HISTONE ACETYLTRANSFERASE BINDING 12 28 0.0003137 0.003835
77 UBIQUITIN LIKE PROTEIN LIGASE BINDING 60 264 0.0003399 0.004101
78 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 69 315 0.0003969 0.004727
79 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY 11 25 0.0004236 0.004981
80 PROTEIN TYROSINE KINASE ACTIVITY 43 176 0.0004671 0.005424
81 GUANYL NUCLEOTIDE BINDING 82 390 0.0004755 0.005454
82 GTPASE BINDING 65 295 0.0004869 0.005516
83 RNA POLYMERASE II TRANSCRIPTION COFACTOR ACTIVITY 26 91 0.0005081 0.005687
84 PHOSPHATIDYLINOSITOL PHOSPHATE BINDING 31 116 0.0005615 0.00621
85 THIOL DEPENDENT UBIQUITIN SPECIFIC PROTEASE ACTIVITY 22 73 0.0006034 0.006595
86 PROTEIN KINASE A BINDING 15 42 0.0006223 0.006722
87 CALMODULIN BINDING 43 179 0.0006803 0.007264
88 PHOSPHATIDYLINOSITOL KINASE ACTIVITY 17 51 0.0006943 0.007329
89 PROLINE RICH REGION BINDING 9 19 0.0007399 0.007638
90 X1 PHOSPHATIDYLINOSITOL BINDING 9 19 0.0007399 0.007638
91 R SMAD BINDING 10 23 0.0008682 0.008767
92 CAMP BINDING 10 23 0.0008682 0.008767
93 TRANSCRIPTION COACTIVATOR ACTIVITY 64 296 0.0008981 0.008971
94 PHOSPHOLIPID TRANSLOCATING ATPASE ACTIVITY 8 16 0.0009416 0.009112
95 CGMP BINDING 8 16 0.0009416 0.009112
96 TRANSLATION REGULATOR ACTIVITY 13 35 0.0009274 0.009112
97 LIPID BINDING 126 657 0.0009834 0.009419
98 PDZ DOMAIN BINDING 25 90 0.001012 0.009597
99 TRANSMEMBRANE TRANSPORTER ACTIVITY 182 997 0.00106 0.009949
NumGOOverlapSizeP ValueAdj. P Value
1 NEURON PART 333 1265 1.006e-28 5.876e-26
2 NEURON PROJECTION 262 942 2.014e-26 5.88e-24
3 CELL PROJECTION 423 1786 6.385e-26 1.243e-23
4 SYNAPSE 214 754 7.076e-23 1.033e-20
5 MEMBRANE REGION 279 1134 1.737e-19 2.029e-17
6 POSTSYNAPSE 123 378 1.254e-18 1.221e-16
7 SOMATODENDRITIC COMPARTMENT 180 650 3.525e-18 2.941e-16
8 PLASMA MEMBRANE REGION 230 929 1.599e-16 1.167e-14
9 DENDRITE 134 451 1.822e-16 1.182e-14
10 CELL JUNCTION 271 1151 2.724e-16 1.591e-14
11 SYNAPSE PART 166 610 4.399e-16 2.335e-14
12 PROTEINACEOUS EXTRACELLULAR MATRIX 107 356 8.969e-14 4.365e-12
13 AXON 119 418 2.495e-13 1.121e-11
14 EXTRACELLULAR MATRIX COMPONENT 52 125 2.897e-13 1.208e-11
15 EXTRACELLULAR MATRIX 120 426 4.41e-13 1.717e-11
16 CELL PROJECTION PART 220 946 8.071e-13 2.946e-11
17 EXCITATORY SYNAPSE 67 197 9.578e-12 3.29e-10
18 CELL BODY 128 494 4.21e-11 1.366e-09
19 SYNAPTIC MEMBRANE 79 261 1.063e-10 3.268e-09
20 BASEMENT MEMBRANE 38 93 8.263e-10 2.413e-08
21 POSTSYNAPTIC MEMBRANE 64 205 1.554e-09 4.321e-08
22 CYTOSKELETON 377 1967 1.096e-08 2.783e-07
23 CELL LEADING EDGE 92 350 1.078e-08 2.783e-07
24 PLASMA MEMBRANE RAFT 34 86 1.716e-08 4.176e-07
25 SITE OF POLARIZED GROWTH 49 149 1.95e-08 4.555e-07
26 MEMBRANE MICRODOMAIN 78 288 3.535e-08 7.94e-07
27 PLASMA MEMBRANE PROTEIN COMPLEX 121 510 3.963e-08 8.572e-07
28 INTRINSIC COMPONENT OF PLASMA MEMBRANE 319 1649 6.766e-08 1.411e-06
29 COATED PIT 28 67 7.585e-08 1.48e-06
30 ANCHORING JUNCTION 116 489 7.603e-08 1.48e-06
31 CELL SUBSTRATE JUNCTION 98 398 1.201e-07 2.262e-06
32 AXON PART 61 219 3.709e-07 6.769e-06
33 PERINUCLEAR REGION OF CYTOPLASM 138 642 2.05e-06 3.628e-05
34 GOLGI APPARATUS 275 1445 2.388e-06 4.102e-05
35 NEURON SPINE 38 121 2.622e-06 4.375e-05
36 ACTIN CYTOSKELETON 101 444 3.881e-06 6.296e-05
37 LAMELLIPODIUM 48 172 5.873e-06 9.27e-05
38 RECEPTOR COMPLEX 78 327 7.985e-06 0.0001227
39 NEURONAL POSTSYNAPTIC DENSITY 21 53 8.705e-06 0.0001304
40 CELL SURFACE 155 757 9.002e-06 0.0001314
41 MICROTUBULE CYTOSKELETON 208 1068 9.542e-06 0.0001359
42 PRIMARY CILIUM 54 205 1.028e-05 0.0001429
43 SARCOLEMMA 37 125 1.599e-05 0.0002172
44 CELL CELL CONTACT ZONE 23 64 2.198e-05 0.000279
45 CYTOPLASMIC SIDE OF MEMBRANE 46 170 2.166e-05 0.000279
46 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 39 136 2.151e-05 0.000279
47 EXTRINSIC COMPONENT OF MEMBRANE 62 252 2.427e-05 0.0003015
48 INTRACELLULAR VESICLE 237 1259 2.645e-05 0.0003218
49 INTERSTITIAL MATRIX 9 14 3.235e-05 0.0003856
50 EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 30 98 4.9e-05 0.0005723
51 FILOPODIUM 29 94 5.551e-05 0.0006356
52 INTERCALATED DISC 19 51 6.341e-05 0.0007121
53 MICROTUBULE END 11 22 0.0001028 0.001133
54 I BAND 34 121 0.0001096 0.001185
55 PLATELET ALPHA GRANULE 24 75 0.0001254 0.001332
56 PRESYNAPSE 65 283 0.0001437 0.001498
57 SIDE OF MEMBRANE 91 428 0.000161 0.001649
58 CYTOSKELETAL PART 260 1436 0.0001656 0.001668
59 COMPLEX OF COLLAGEN TRIMERS 11 23 0.0001709 0.001691
60 NEURON PROJECTION TERMINUS 35 129 0.0001869 0.001819
61 CENTROSOME 101 487 0.0001931 0.001849
62 MICROTUBULE ORGANIZING CENTER 124 623 0.0002403 0.002263
63 TRANSPORTER COMPLEX 71 321 0.0002448 0.00227
64 MICROTUBULE 86 405 0.0002508 0.002288
65 MICROTUBULE PLUS END 9 17 0.0002576 0.002315
66 CATION CHANNEL COMPLEX 42 167 0.0002815 0.002491
67 NONMOTILE PRIMARY CILIUM 36 137 0.000302 0.002632
68 CYTOPLASMIC REGION 63 287 0.0006526 0.005605
69 CONTRACTILE FIBER 49 211 0.0006842 0.005791
70 OUTER MEMBRANE 45 190 0.0007147 0.005963
71 MEMBRANE PROTEIN COMPLEX 187 1020 0.0007375 0.006066
72 ACTIN BASED CELL PROJECTION 43 181 0.0008666 0.007029
73 APICAL PLASMA MEMBRANE 63 292 0.001037 0.008297
74 CELL PROJECTION MEMBRANE 64 298 0.001075 0.008485
75 ENDOPLASMIC RETICULUM 284 1631 0.001093 0.008512
76 APICAL PART OF CELL 75 361 0.001146 0.00865
77 CLATHRIN COATED VESICLE 38 157 0.001163 0.00865
78 AXONAL GROWTH CONE 9 20 0.00117 0.00865
79 FILAMENTOUS ACTIN 9 20 0.00117 0.00865
80 VACUOLE 211 1180 0.001299 0.009485

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04510_Focal_adhesion 62 200 3.781e-09 6.806e-07
2 hsa04014_Ras_signaling_pathway 65 236 2.445e-07 1.655e-05
3 hsa04270_Vascular_smooth_muscle_contraction 39 116 2.758e-07 1.655e-05
4 hsa04020_Calcium_signaling_pathway 50 177 2.592e-06 0.0001167
5 hsa04310_Wnt_signaling_pathway 44 151 4.18e-06 0.0001505
6 hsa04540_Gap_junction 30 90 7.676e-06 0.0002303
7 hsa04360_Axon_guidance 38 130 1.696e-05 0.0004362
8 hsa04010_MAPK_signaling_pathway 65 268 2.53e-05 0.0005693
9 hsa04720_Long.term_potentiation 24 70 3.599e-05 0.0007199
10 hsa04512_ECM.receptor_interaction 27 85 5.633e-05 0.001014
11 hsa04810_Regulation_of_actin_cytoskeleton 53 214 7.563e-05 0.001165
12 hsa04520_Adherens_junction 24 73 7.765e-05 0.001165
13 hsa04070_Phosphatidylinositol_signaling_system 25 78 8.886e-05 0.00123
14 hsa04971_Gastric_acid_secretion 24 74 9.901e-05 0.001273
15 hsa04730_Long.term_depression 23 70 0.0001098 0.001317
16 hsa04151_PI3K_AKT_signaling_pathway 77 351 0.0001807 0.002033
17 hsa04916_Melanogenesis 29 101 0.0002268 0.002401
18 hsa04350_TGF.beta_signaling_pathway 25 85 4e-04 0.004
19 hsa04722_Neurotrophin_signaling_pathway 33 127 0.000653 0.006186
20 hsa04910_Insulin_signaling_pathway 35 138 0.0007365 0.006628
21 hsa04390_Hippo_signaling_pathway 38 154 0.0007908 0.006778
22 hsa04912_GnRH_signaling_pathway 26 101 0.002666 0.02182
23 hsa02010_ABC_transporters 14 44 0.003282 0.02569
24 hsa04920_Adipocytokine_signaling_pathway 19 68 0.003612 0.02702
25 hsa04710_Circadian_rhythm_._mammal 9 23 0.003752 0.02702
26 hsa04970_Salivary_secretion 23 89 0.004321 0.02992
27 hsa00350_Tyrosine_metabolism 13 41 0.004693 0.03129
28 hsa04972_Pancreatic_secretion 25 101 0.00552 0.03549
29 hsa04012_ErbB_signaling_pathway 22 87 0.006817 0.04231
30 hsa04514_Cell_adhesion_molecules_.CAMs. 31 136 0.007991 0.04795
31 hsa04144_Endocytosis 42 203 0.01339 0.07778
32 hsa04960_Aldosterone.regulated_sodium_reabsorption 12 42 0.01564 0.08773
33 hsa00562_Inositol_phosphate_metabolism 15 57 0.01608 0.08773
34 hsa04962_Vasopressin.regulated_water_reabsorption 12 44 0.02255 0.1194
35 hsa04914_Progesterone.mediated_oocyte_maturation 20 87 0.02662 0.1369
36 hsa00534_Glycosaminoglycan_biosynthesis_._heparan_sulfate 8 26 0.02927 0.1463
37 hsa04530_Tight_junction 28 133 0.03089 0.1503
38 hsa04210_Apoptosis 20 89 0.03331 0.1559
39 hsa04670_Leukocyte_transendothelial_migration 25 117 0.03379 0.1559
40 hsa04115_p53_signaling_pathway 16 69 0.04106 0.1848
41 hsa04114_Oocyte_meiosis 24 114 0.04316 0.1895
42 hsa00300_Lysine_biosynthesis 2 3 0.05888 0.2523
43 hsa04320_Dorso.ventral_axis_formation 7 25 0.06449 0.2699
44 hsa00120_Primary_bile_acid_biosynthesis 5 16 0.07451 0.2985
45 hsa00230_Purine_metabolism 31 162 0.07462 0.2985
46 hsa00360_Phenylalanine_metabolism 5 17 0.09325 0.3516
47 hsa04614_Renin.angiotensin_system 5 17 0.09325 0.3516
48 hsa00532_Glycosaminoglycan_biosynthesis_._chondroitin_sulfate 6 22 0.09376 0.3516
49 hsa04664_Fc_epsilon_RI_signaling_pathway 16 79 0.1135 0.4109
50 hsa00670_One_carbon_pool_by_folate 5 18 0.1141 0.4109
51 hsa00760_Nicotinate_and_nicotinamide_metabolism 6 24 0.1314 0.4637
52 hsa00071_Fatty_acid_metabolism 9 43 0.1743 0.6033
53 hsa00982_Drug_metabolism_._cytochrome_P450 14 73 0.1812 0.6155
54 hsa00280_Valine._leucine_and_isoleucine_degradation 9 44 0.1923 0.6409
55 hsa04974_Protein_digestion_and_absorption 15 81 0.2079 0.675
56 hsa04145_Phagosome 27 156 0.2121 0.675
57 hsa00740_Riboflavin_metabolism 3 11 0.2137 0.675
58 hsa04640_Hematopoietic_cell_lineage 16 88 0.2197 0.682
59 hsa03320_PPAR_signaling_pathway 13 70 0.2261 0.6899
60 hsa00340_Histidine_metabolism 6 29 0.2494 0.7483
61 hsa04630_Jak.STAT_signaling_pathway 26 155 0.2694 0.7886
62 hsa04130_SNARE_interactions_in_vesicular_transport 7 36 0.2754 0.7886
63 hsa00512_Mucin_type_O.Glycan_biosynthesis 6 30 0.276 0.7886
64 hsa00564_Glycerophospholipid_metabolism 14 80 0.2871 0.8076
65 hsa04662_B_cell_receptor_signaling_pathway 13 75 0.3096 0.8572
66 hsa00310_Lysine_degradation 8 44 0.3195 0.8713
67 hsa03450_Non.homologous_end.joining 3 14 0.342 0.9188
68 hsa04150_mTOR_signaling_pathway 9 52 0.3577 0.9441
69 hsa04062_Chemokine_signaling_pathway 30 189 0.3619 0.9441
70 hsa01040_Biosynthesis_of_unsaturated_fatty_acids 4 21 0.3762 0.9539
71 hsa00600_Sphingolipid_metabolism 7 40 0.3763 0.9539
72 hsa00072_Synthesis_and_degradation_of_ketone_bodies 2 9 0.392 0.9801
73 hsa00410_beta.Alanine_metabolism 4 22 0.4118 1
74 hsa00770_Pantothenate_and_CoA_biosynthesis 3 16 0.4274 1
75 hsa04744_Phototransduction 5 29 0.4296 1
76 hsa04666_Fc_gamma_R.mediated_phagocytosis 15 95 0.4313 1
77 hsa00270_Cysteine_and_methionine_metabolism 6 36 0.4428 1
78 hsa00565_Ether_lipid_metabolism 6 36 0.4428 1
79 hsa00430_Taurine_and_hypotaurine_metabolism 2 10 0.4467 1
80 hsa00591_Linoleic_acid_metabolism 5 30 0.4603 1
81 hsa00650_Butanoate_metabolism 5 30 0.4603 1
82 hsa03022_Basal_transcription_factors 6 37 0.4704 1
83 hsa04973_Carbohydrate_digestion_and_absorption 7 44 0.4784 1
84 hsa04976_Bile_secretion 11 71 0.481 1
85 hsa03420_Nucleotide_excision_repair 7 45 0.5034 1
86 hsa00250_Alanine._aspartate_and_glutamate_metabolism 5 32 0.5201 1
87 hsa00260_Glycine._serine_and_threonine_metabolism 5 32 0.5201 1
88 hsa00640_Propanoate_metabolism 5 32 0.5201 1
89 hsa04380_Osteoclast_differentiation 19 128 0.5269 1
90 hsa00601_Glycosphingolipid_biosynthesis_._lacto_and_neolacto_series 4 26 0.5476 1
91 hsa04610_Complement_and_coagulation_cascades 10 69 0.5765 1
92 hsa04370_VEGF_signaling_pathway 11 76 0.5771 1
93 hsa03015_mRNA_surveillance_pathway 12 83 0.5779 1
94 hsa00592_alpha.Linolenic_acid_metabolism 3 20 0.5832 1
95 hsa00380_Tryptophan_metabolism 6 42 0.6006 1
96 hsa00980_Metabolism_of_xenobiotics_by_cytochrome_P450 10 71 0.6145 1
97 hsa00480_Glutathione_metabolism 7 50 0.6207 1
98 hsa00561_Glycerolipid_metabolism 7 50 0.6207 1
99 hsa00051_Fructose_and_mannose_metabolism 5 36 0.6299 1
100 hsa04660_T_cell_receptor_signaling_pathway 15 108 0.6417 1
101 hsa00590_Arachidonic_acid_metabolism 8 59 0.658 1
102 hsa00604_Glycosphingolipid_biosynthesis_._ganglio_series 2 15 0.6721 1
103 hsa00910_Nitrogen_metabolism 3 23 0.6807 1
104 hsa03060_Protein_export 3 23 0.6807 1
105 hsa04975_Fat_digestion_and_absorption 6 46 0.691 1
106 hsa04260_Cardiac_muscle_contraction 10 77 0.7171 1
107 hsa04110_Cell_cycle 17 128 0.7182 1
108 hsa04340_Hedgehog_signaling_pathway 7 56 0.7387 1
109 hsa04146_Peroxisome 10 79 0.747 1
110 hsa04672_Intestinal_immune_network_for_IgA_production 6 49 0.7492 1
111 hsa04120_Ubiquitin_mediated_proteolysis 18 139 0.7607 1
112 hsa00531_Glycosaminoglycan_degradation 2 19 0.7936 1
113 hsa04650_Natural_killer_cell_mediated_cytotoxicity 17 136 0.8047 1
114 hsa04141_Protein_processing_in_endoplasmic_reticulum 21 168 0.8249 1
115 hsa00500_Starch_and_sucrose_metabolism 6 54 0.8278 1
116 hsa04612_Antigen_processing_and_presentation 9 78 0.8318 1
117 hsa04330_Notch_signaling_pathway 5 47 0.8428 1
118 hsa00620_Pyruvate_metabolism 4 40 0.8611 1
119 hsa00010_Glycolysis_._Gluconeogenesis 7 65 0.8629 1
120 hsa04142_Lysosome 14 121 0.8706 1
121 hsa03430_Mismatch_repair 2 23 0.8735 1
122 hsa04964_Proximal_tubule_bicarbonate_reclamation 2 23 0.8735 1
123 hsa04977_Vitamin_digestion_and_absorption 2 24 0.8884 1
124 hsa00860_Porphyrin_and_chlorophyll_metabolism 4 43 0.8964 1
125 hsa04742_Taste_transduction 5 52 0.8992 1
126 hsa00563_Glycosylphosphatidylinositol.GPI..anchor_biosynthesis 2 25 0.9017 1
127 hsa04622_RIG.I.like_receptor_signaling_pathway 7 71 0.9151 1
128 hsa04966_Collecting_duct_acid_secretion 2 27 0.9239 1
129 hsa00240_Pyrimidine_metabolism 10 99 0.9328 1
130 hsa03440_Homologous_recombination 2 28 0.9332 1
131 hsa00140_Steroid_hormone_biosynthesis 5 57 0.9371 1
132 hsa00510_N.Glycan_biosynthesis 4 49 0.944 1
133 hsa04620_Toll.like_receptor_signaling_pathway 10 102 0.9465 1
134 hsa04621_NOD.like_receptor_signaling_pathway 5 59 0.9483 1
135 hsa00330_Arginine_and_proline_metabolism 4 54 0.9674 1
136 hsa00830_Retinol_metabolism 5 64 0.9688 1
137 hsa03410_Base_excision_repair 2 34 0.9699 1
138 hsa04140_Regulation_of_autophagy 2 34 0.9699 1
139 hsa00514_Other_types_of_O.glycan_biosynthesis 3 46 0.9743 1
140 hsa03030_DNA_replication 2 36 0.977 1
141 hsa00520_Amino_sugar_and_nucleotide_sugar_metabolism 3 48 0.9798 1
142 hsa03018_RNA_degradation 5 71 0.9851 1
143 hsa04623_Cytosolic_DNA.sensing_pathway 3 56 0.9926 1
144 hsa03008_Ribosome_biogenesis_in_eukaryotes 5 81 0.9951 1
145 hsa00983_Drug_metabolism_._other_enzymes 2 52 0.9975 1
146 hsa03013_RNA_transport 11 152 0.9985 1
147 hsa03010_Ribosome 5 92 0.9986 1
148 hsa00970_Aminoacyl.tRNA_biosynthesis 2 63 0.9995 1
149 hsa03040_Spliceosome 6 128 0.9999 1
150 hsa00190_Oxidative_phosphorylation 4 132 1 1
151 hsa04740_Olfactory_transduction 12 388 1 1

Quest ID: 13dd22306a00fe1083c9efc64dc6845e